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1 
1. Introduction 
 
1.1 Aim of the Thesis 
 
This thesis has been carried out at the Department of Chemistry of Naples University, 
Italy, and at the Department of Physical Chemistry 1 at Lund University, Sweden, 
during the period 2005-2008.  
The aim of the thesis has been the design and the physico-chemical characterization 
of amphiphilic superstructures, such as micelles and liposomes, to be used as nano-
devices in cancer diagnosis and therapy. 
The past quarter century of outstanding progress in fundamental cancer biology has 
not translated into even comparable advances in the clinic. Inadequacy in the ability 
to administer therapeutic moieties, so that they will selectively reach the desired 
targets with marginal or no collateral damage, has largely accounted for this 
discrepancy.
1,2 Similar limitations apply to contrast agents for imaging applications. 
There are two synergistic goals that should be striven for to increase the efficacy per 
dose of any therapeutic or imaging contrast formulation: to increase its targeting 
selectivity
3 and to endow the agent comprising the therapeutic or the diagnostic 
formulation with the means to overcome the biological barriers that prevent it from 
reaching its target.
4 An ideal therapeutic system would be selective directed against 
cell clusters that are in the early stages of the transformation towards the malignant 
phenotype.
5  
The realization of such a system faces different challenges, including the 
identification of suitable bio-active molecules or chemical processes able either to 
deliver the therapeutic/contrast agent toward the cancer cells or to avoid biological 
and biophysical barriers. 
On these bases two different systems have been developed in the present research 
project: 1) The first system was formed by two amphiphilic unimers, one chelating a 
Gadolinium complex, that is the most common contrast agent used in Magnetic 
Resonance Imaging (MRI), the leading technique for the diagnosis of tumors, and 
the other one containing a peptide, the CCK8, showing high affinity for the 
cholecystokinin receptors which are overexpressed in different tumor pathologies. 2) 
The second system was formed by a unimer containing a pyridinium ring able to 
coordinate Ru(III) complexes, which offer new interesting perspectives in the 
selective attack of tumor metastases. 
 
 
 
 
 
 
 
 
 
 
1.2 Surfactants in Aqueous Solution 
 
1.2.1 Surfactants  
 
The basic molecular architecture of surfactants is always based on the simultaneous 
presence in the same molecule of two or more groups of atoms that possess different 
affinities for the environmental (solvent). In most of the cases the solvent is water, 
and so we distinguish a hydrophilic part (the "polar headgroups") linked to a 
hydrophobic block made up by one or more hydrocarbon chains.
6
 
Depending on the nature of the hydrophilic head, surfactants can be divided into 
ionic and non-ionic type. The ionic head can be negatively charged, such as in the 
case of carboxylates (-COO- ), sulfates (-OSO3- ), sulfonates (-SO3-); or positively 
charged, with an quaternary ammonium head group (-NH3+,-NR3+); while the non-
ionic head can be zwitterionic, two oppositely charged groups, or composed of an 
etoxylate chain –(OCH2 CH2)mOH . 
 
1.2.2 Amphiphilic assembly processes  
 
Depending on the chemical structure of the amphiphile, temperature, pH and ionic 
strength of the solution, nature and composition of the solvent, different kinds of 
aggregates with peculiar properties can be obtained. They originate by the assembly 
of surfactants in order to reduce the hydrocarbon-water repulsion and then 
minimizes the total energy of the aggregate. It is possible to predict the type of phase 
that a surfactant forms using the surfactant parameter Ns:
7
 
 
 0alvN s ⋅=   (1.0) 
where v  is the volume of the surfactant hydrophobic tail, l  is the length of the 
hydrocarbon chain, and 
oa  is the effective area per head group. 
 
 
 
 
Figure 1.1: Schematic illustration of association structures formed in surfactant systems and their 
relative packing parameters. 
 
For Ns < 1/3, spherical micelles will form, for Ns = ½ cylindrical micelles are expected 
instead. 
Bilayers as well as bicontinous phases form for Ns = 1 while reverse structures are 
expected for Ns> 1. 
The aggregates which have interested this thesis work are: micelles, vesicles and 
bilayers assemblies.  
Micelles are the simplest and the most characterized self-organizing structures. The 
process of micellization is a start-stop process. This means that there is a well-defined 
point where process starts and one of stop too. The point of start is represented by the 
critical micellar concentration (CMC). The CMC is the lowest concentration where 
micelles are formed. Below CMC value the surfactants are in solution as free unimers, 
while above the CMC adding more surfactants produces more micelles with a well-
defined aggregation number rather than larger micelles. The growth process is 
limited in fact from head-group head-group repulsion, so aggregates cease to grow 
when they reach a certain size. 
The micellar aggregation process can be described by a stepwise association process, 
S + Sn-1↔ Sn, but because it is almost impossible to specify all the Kn equilibrium 
steps, approximate models are used.
8
 The most important models to describe the 
micellization process are the “isodesmic model” that assumes that Kn is independent 
of n and the “phase separation model” that approximates aggregation as a phase 
separation process. In particular, in the phase separation model the aggregation is 
described as a discontinuous process that shows an abrupt onset in a narrow 
concentration range, so this model is able to predict the CMC and is appropriate for 
surfactants with long hydrocarbon chains and low CMC, such as the surfactants used 
in this work. 
The bilayer aggregation process is less studied than micellization process, because 
most experimental techniques are not sensitive enough to low concentrations. In fact, 
the solubility of bilayer-forming monomers, such as phospholipids, which usually 
have two apolar chains, is much lower than micelle-forming surfactants solubility, 
which have generally one tail. For bilayers, the aggregation monomer’s solubility 
defines the start of the process, but there is no molecular limit to bilayer growth in 
the lateral direction, so there is no a point of stop that limits the process of 
aggregation of bilayers whom thickness is a well-defined property determined by the 
length of the hydrocarbon chains. Lifetimes for micelles and bilayers are really 
different, for micelles it can vary from 10-3 to 10-1 s, while for bilayers the lifetime of 
the aggregate can vary from days to years. This difference reflects the fact that 
micelles are in dynamic equilibrium with free surfactants in the bulk aqueous 
solution, so surfactant in solution is continuously exchanged with surfactant in the 
micelle, causing the constant rupture and re-formation of micelles in solution. In 
contrast, vesicles are far less susceptible to break-down as a result of sluggish 
monomer exchange processes. Bilayers are the basic structural element in several 
phases, including lamellar liquid crystals and gel phases.The lamellar liquid crystal is 
the generic bulk phase of a bilayer-forming amphiphile, and it consists of a stack of 
bilayers, with the apolar chains behaving as in a liquid, separated by aqueous films. 
When a lamellar phase is cooled, it undergoes a phase change that can lead to the 
formation of a gel phase. Typical gel structures present crystallized alkyl chains while 
liquidlike solvent still exists between the bilayers.  
The gel-to-liquid crystal transition can be studied by differential scanning calorimetry 
(DSC); two peaks can be observed, the first of which, the pre-transition, corresponds 
to a disordering of the bilayer membrane in the absence of chain-melting, while the 
second one is very pronounced and corresponds to chain melting.
9
 
Bilayers form the basic structural element in other ordered phases; in isotropic 
solutions they can form vesicles. 
Vesicles are hollow spheres consisting of at least one surfactant bilayer, unilamellar 
vesicles, but they can also present more bilayers, multilamellar ones. 
Vesicles are important biological structures, the surfactant bilayer mimics the lipid 
bilayer of cell membranes, in fact the cell is an example of a very complex biological 
vesicle.  
Their ability to encapsulate an aqueous environment makes them suitable for many 
applications, above all, in pharmaceutical setting, where they are used as carriers of 
drugs
10
 or as models for biological membranes.
11
 
 
 
 
Figure 1.2: Schematic representation of a vesicular structure, observed on a little scale, its surface can 
be considered as a thickness of a lipidic bilayer. 
 
Spontaneous vesicles of certain surfactants under favorable conditions have been 
reported, but vesicles are usually formed from lamellar dispersions with an input of 
energy. There are several ways to provide energy, the methods used in this work are: 
sonication and extrusion. The sonication method is a non selective way to produce 
vesicles, the sound waves tear the lamellae, which can reseal to form vesicles, the 
resulting consists in a distribution of unilamellar and small vesicles (SUV) with 
diameters in the range of 15-50 nm. In the extrusion method the lamellar suspension 
is forced through a polycarbonate filter with a defined pore size to yield particles 
having a diameter near the pore size of the filter used. Extrusion through filters with 
100 nm pores typically produce large and unilamellar vesicles (LUV) with a mean 
diameter of 120-140 nm. 
In any case vesicles produced with these two methods are metastable structures, this 
means that the vesicles will relax back to their equilibrium structure of lamellar 
phase, but this process is usually really sluggish, it can take days, months or years. 
Khan et all have shown that the formation of stable vesicle is possible, without 
recourse to highly energetic methods, such as sonication and extrusion, using 
“catanionic surfactants”.
12,13
 Catanionic surfactants are equimolar mixtures of two 
oppositely charged surfactants, where the effective head group size becomes much 
smaller than the sum of the head group areas for the separate systems, since the 
amphiphiles attract one another by electrostatic interaction. According to the 
principle of reducing the head group area to obtain low radius curvature aggregate, it 
is possible to promote in solution the transition from micelles to vesicles in ionic 
systems modifying appropriately the pH. A rather large number of studies on the pH-
dependent behaviour of gemini surfactants, molecules made of two conventional 
surfactant units connected by a spacer, have been published in the recent years.
14, 15
 
In literature it is possible to find also different works about the inverse transition; 
non-ionic micelle-forming surfactants are especially adapt to yield vesicle to micelle 
transition of cationic unilamellar vesicles. All these studies reveal that the transition 
occurs by an intermediate stage, where rodlike and threadlike micelles are formed, 
confirming so the three-stage Lichtenberg model.
16, 17
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.3 Surfactants in Pharmaceutics and Diagnostics 
 
In the last years the use of nanovectors, namely supramolecular structures with 
dimensions of the order of nanometers, is becoming very appealing in the drug 
delivery field. They are able to carry an active substance through the aqueous 
biological system, and their typical size in the nanometer scale, which is of the same 
order of the human cells, allows them delivering the drug to the targeted site. 
However, drug delivery requires stringent conditions. The drug concentration must 
be in the therapeutic window, i.e. high enough to achieve a therapeutic effect at the 
site of action, but simultaneously low enough to avoid harmful side effects elsewhere. 
Then, the role of the supramolecular structures is not only to carry the drugs, but also 
to protect the active ingredients from destructive factor, and to control their spatial 
and temporal distribution through the biological system. Furthermore, the 
nanovector must be formed by molecules themselves non-toxic, that can be 
metabolized to harmless compounds. 
Among the different nanovectors, those formed by amphiphilic molecules have 
recently drawn much attention owing to their good pharmacological properties. By 
operating on the different chemical structures of the amphiphilic molecules 
composing the super-aggregates, it is possible to build-up nanovectors different for 
shape, dimension and physico-chemical characteristics.  
The most common structures are micelles and liposomes, whose physico-chemical 
characteristics have been discussed above. They possess some advantages as potential 
drug delivery systems, since they can encapsulate a variety of sparingly water-soluble 
therapeutic and diagnostic agents. Such encapsulation substantially increases their 
bioavailability, protects them from destructive factors upon parenteral 
administration, and modifies their pharmacokinetics and biodistribution. 
The most used amphiphilic aggregates for drug delivery purposes are liposomes. The 
first use of liposomes as nanovectors was in the anti-microbic and anti-fungal 
therapy. In fact, it is well-known that liposomes, given by endovenous injection, are 
assimilated by hepatic macrophages through the endocytosis mechanism that in turn 
is able to deliver them to lisosomes or to some other cytoplasmatic regions in which 
the drug can act.  
Liposomes can be administrated not only via endovenous injection but also via: 1) 
aerosol, useful for pulmonary pathologies treatments, 2) subcutaneous or muscular 
injection able to transmit these nanovectors to the lymphatic ways, and 3) oral 
assumption.  
Liposomes success in the field of drug delivery is due to several factors that can be 
summarized in the experimental evidence that these nanovectors are able to improve 
the therapy results respect to what is obtained administrating the same active 
principle in a more classic way.  
The use of nanovectors such as liposomes allows reaching high concentration level of 
the drug in the ill tissues, but at the same time its inclusion into a supromolecular 
structure limits its toxicity preventing undesidered sides, concentration peak effects 
and prolonging the permanence time of the drug in the blood stream. Typical 
examples, confirming all this, are liposomes based doxorubicine that have been used 
in the past for the treatment of Karposi sarcoma, while nowadays they are used in the 
breast and ovaries tumor therapy.  
One limitation to the use of liposomes and micelles in pharmacology stayed in the 
fact that they often were recognized as extraneous bodies by the immunitary system 
with the consequence to be eliminated before they can reach and act on the ill tissues. 
Pegylated liposomes or micelles, namely aggregates covered by a polyethileneglycol 
film, are the right answer to this problem because polyethileneglycol is an inert 
chemical substance that does not alert the immunitary system. So tailored 
amphiphilic complexes freely circulate in the blood stream for 2-3 weeks and they 
have the time to get into the blood vessels generated the tumor itself. An example of 
this behavior is the pegylated doxorubicine (Caelyx®). 
The inclusion of anti-neoplastic drugs into liposomes has been accepted by several 
pharmaceutical industries and several products have been put in the market. 
Hereafter, there is a list of liposomial formulations approved or in clinical 
experimentation. 
 
 
 
 
 
 
 
 
Table. Liposomial formulation approved or in clinical experimentation. 
 
 
To further increase liposomal and micellar drug accumulation in the desired tissues 
and organs, thus maximizing the therapeutic efficacy of the drug and reducing its 
systemic side-effects, it is important to develop active targeting of particulates that 
carry physically entrapped drugs.  
To attain active targeting of a drug carrier, nanovectors may be derivatized with 
ligands that bind to specific receptors expressed on target cells. The list of ligands 
that are used to derivatize nanovectors for selective drug delivery includes a wild 
range of synthetic and natural compounds of different chemical classes: antibodies or 
antibody fragments, low molecular weight organic molecules (e.g. folic acid) or 
natural peptides. 
Immunoglobulins (Ig) of the IgG class and their fragments are the most widely used 
targeting moieties for amphiphilic aggregates, because the covalent binding to the 
aggregate surface or the hydrophobic insertion into the liposomal membrane or 
                  Drug 
 
Commercial name Therapeutical 
indication 
Daunorubicine DaunoXome Kaposi Sarcoma 
Doxorubicine Myocet Breast cancer 
Doxorubicine in pegylated 
liposomes 
Doxil/Caelyx Kaposi Sarcoma, Breast 
cancer, Ovaries cancer 
Amphotericin B AmBisome Fungal inflammation 
Cytarabine DepoCyt Meningitis 
Vincristine Onco TCS Non-Hodgkin lymphoma 
Lurtotecan NX211 Ovaries cancer 
Nystatin Nyotran Fungal inflammation 
Retinoic Acid Altragen 
 
 
Leukaemia, Non-Hodgkin 
lymphoma, Renal cells 
carcinoma, Kaposi Sarcoma 
Pt Complexes Platar Solid tumors 
micellar core don’t affect either the integrity of the aggregate or the antibody 
properties. However, in spite of recent advances in antibody engineering, they remain 
expensive and time-consuming to produce, and problems with stability and storage 
exist. Moreover, the majority of antibody targeted aggregates accumulate in the liver 
as a consequence of insufficient time for the interaction between the target and the 
targeted liposomes. 
Targeting tumours with folate-modified aggregates represents a popular approach, 
because folate receptors (FR) are frequently overexpressed in many tumour cells. 
Liposomal daunorubicin
18 as well as doxorubicin
19
 have been delivered into various 
tumour cells through FR. Recently, the application of folate modified doxorubicin-
loaded liposomes to the treatment of acute myelogenous leukaemia was combined 
with the induction of FR using all-trans retinoic acid.
20
 
The use of peptides as targeting tools has been validated in a number of 
applications.
21
 Small peptides are, in fact, excellent candidates for the development of 
target-specific pharmaceuticals, because they are easy to synthesize and modify, less 
likely to be immugenic, and can have fast blood clearance. One example are 
radiolabeled peptides which are used in nuclear medicine techniques to perform 
imaging or to deliver radiotherapeutic doses to cancer tissues overexpressing 
particular types of receptors, such as those for somatostatin.
22
 In this case, a simple 
entity such as the radionuclide is driven by the peptide to target cells at higher 
concentrations compared to non-target organs. 
 
1.4 Magnetic Resonance Imaging (MRI): A fundamental tool in tumor 
diagnosis 
 
MRI is an imaging technique used in medical settings to produce high quality images 
of the inside of the human body. It measures the characteristics of hydrogen nuclei of 
the water contained in the human tissues, modified by chemical environment;
23, 24
 
providing the spatial distribution of the intensity of water proton signal in the volume 
of the body.  
The spatial information is recovered through the additional application of three 
mutually perpendicular magnetic fields (gradient fields): one to select the slice and 
two to encode spatial information (Figure 1.3). 
 
 
Figure 1.3: The signals and the spectra obtained from three water’s samples in different positions on 
x axes. In presence of the gradient the signals are resolved and the separation depends from the spatial 
separation in the x versus and from the intensity of the gradient field. 
The signal intensity in MRI depends on the amount of water in the given tissue and 
on the magnetic relaxation times T1 and T2, respectively the spin-lattice relaxation 
time and the spin-spin relaxation time.  
The success of MRI is related to the coincidence that proton relaxation times are 
dependent on the physicochemical environment of a given tissue and so they are 
modified in presence of a pathological state. Thus, in conditions of optimal contrast, 
there is a clear distinction between healthy and diseased tissues.  
The contrast in MR images is influenced by a range of factors such as the proton 
density and the relaxation times T1 and T2. The proton density in the tissue is 
obviously problematic to modify. The most modifiable factors are the magnetic 
relaxation times T1 and T2.
25 The spin-lattice relaxation time T1 and the spin-spin 
relaxation time T2 may be shortened considerably in presence of paramagnetic 
species leading to different effects. While shortening of T1 leads to increase in signal 
intensity, shortening of T2 produces broader lines with decreased intensity.
26 In 
current medical diagnostics, the most frequently used contrast agents (CA) are T1 
agents. The contrast agents contain magnetic centers that interact with water 
protons in exactly the same way as the neighboring protons, but with much 
stronger magnetic fields, and therefore, have a much greater impact on 
relaxation rates.  
Among the paramagnetic species, due to its high number of unpaired electrons, 
the paramagnetic metal ion Gd3+ in its complexed form, otherwise it would be toxic, 
is the most diffused. 
The first contrast agent approved for clinical use was the anionic complex Gd-DTPA 
(diethylenetriaminepentaacetate acid) under the trade name of Magnevist (Shering 
AG Germany). In Figure 1.4 are reported some examples of Gd3+ based contrast 
agents with the corresponding thermodynamic stability constants (usually between 
1016 to 1023) measured at 25° C and µ=0.1 M: Gd-DOTA ( DOTA= 1,4,7,10-
tetraazacyclo-dodecan-1,4,7,10- tetraacetic acid, Dotarem Guerbet SA, France), Gd-
HPDO3A (PHDO3A=1,4,7,10-tetraazacyclo-dodecan-1-(2-hydoxypropyl)-4,7,10- 
triacetic acid; Prohance, Bracco Imaging, Italy) and Gd-DTPA-BMA (BMA= 
bismethylamide; Omniscan, Amersham-Hycomed, Norway) (Figure 1.2). 
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Figure 1.4: Schematic representation of four ligands whose, Gd3+ chelates are currently used as CA 
for MRI. Thermodynamic stabilities of the complexes at 25°C and µ=0.1 M are reported. 
 
The efficiency of a CA, the capacity to shorten the longitudinal relaxation time of the 
water protons present in the coordination sphere of the metal complex, is expressed 
as proton relaxivity (r1), which defines the increase in longitudinal water proton 
relaxation rate per millimolar concentration of Gd3+. 
The observed water proton longitudinal relaxation rate
27 (eq.1.1) in a solution 
containing a paramagnetic metal complex is given by the sum of three contributions:  
 
 is1 1p 1 1
obs os w
pR R R R= + +  (1.1) 
 
where 1
wR is the water relaxation rate in the absence of the paramagnetic compound, 
1
is
pR the contribution due to the exchange of water molecules from the inner 
coordination sphere of the metal ion to the bulk water and 1
os
pR , finally, the 
contribution of solvent molecules diffusing in the outer coordination sphere of the 
paramagnetic center. The overall paramagnetic relaxation enhancement ( 1 1
is os
p pR R+ ) 
referred to by a 1 mM concentration of a given Gd3+ chelate is called relaxivity (Figure 
1.5). 
 
  
Figure 1.5: Schematic view of the relaxation mechanisms operating in an aqueous solution containing 
a paramagnetic Gd3+ chelate. 
 
The inner sphere relaxation rate is described in terms of the following set of 
equations (eq. 1.2-1.4), which correspond to the model developed by Solomon-
Bloembergen-Morgan:
28
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where: c is the molar concentration of the paramagnetic complex; q is the number of 
water molecules coordinated to the metal ion; Mτ is the mean residence lifetime; 1MT is 
their longitudinal relaxation time; K is the value of dipolar interaction between 
coordinated water’s protons and the unpaired electrons; Rτ the reorientation 
correlation time; and Sτ  is the electron spin relaxation time. 
The ability of Gd3+ chelates to enhance the relaxivity is mainly determined by the 
value of their molecular reorientation time, Rτ , which depends upon the molecular 
dimension of the complexes. Therefore, the achievement of higher water proton 
relaxation rates may be pursued through the employment of macromolecular contrast 
agent, which allows also carrying a high concentration (10-2 M) of contrast agent. At 
this aim many supramolecular systems have been developed such as liposomes
29
 and 
other microparticulates,
30 micelles,
31 dendrimers,
32 linear polymers,
33 proteins,
34 or 
peptides,
35 all of these derivatized with the metal-complex of interest. Among those 
carriers, micelle and vesicular aggregates have recently drawn much attention owing 
to their easy controlled properties and good pharmacological characteristics.  
1.5 Metal Complexes in tumor therapy  
 
Since 1965, when the neoplastic activity of cis-Platinum was discovered,
36
 this 
transition metal has been becoming one of the most used chemicals in the treatment 
of some tumoral diseases; such as testicle, mammalian, uterine and ovarian cancers.
37
  
Many Pt-based complexes have been synthesized, the most successful are: cis-
Platinum, Carbo-Platinum
38 and Oxali-Platinum
39
. 
 
 
 
Figure 1.6: Schematic structures of some Platinum complexes. 
 
In 1979 the Food and Drugs Administration adopted cis-Pt as human drug. 
Nevertheless other transition metals have been taken into account in the cancer 
treatment with the aim to substitute Pt, because of its gastric and renal toxicity. The 
use of cis-Pt is also limited by problems connected with the resistance induced in 
patients and for its chemo-activity only on few tumoral forms.
40
 
It has been proposed that Pt-complexes renal and gastric toxicity is the consequence 
of the inactivation of sulfured enzymes due to the bonds that Pt directly forms with 
the sulfur sites. 
The setting-up of sulfured chemo-protectors, mainly thiols and thiocarbamates, is a 
good strategy to overcome this problem. In fact, these chemicals are able to bind Pt 
ions not allowing their direct interaction with sulfured enzymes; but although this 
winning strategy, the toxicity of Pt-based drugs remains considerable. This is the 
reason why researchers are paying attention on other metals,
41 such as Titanium
42
, 
Rhodium
43
, Iridium
44
 and Ruthenium
45
. In relation to this last metal, it is Ru+2 (from 
now on Ru(II)), that shows good anti-tumoral and anti-metastatic activity 
46
, together 
with a lower toxicity in comparison with that of Pt complexes. In particular Ru(II)-
amine complexes are at present preferred for the reproducibility of their synthesis 
and for the stability of the complexes, but above all because of their specificity for 
proteins, oligonucleotides and nucleic acids of specific tissues.
47
 
Although only Ru(II), among all the Ru oxidation states shows anti neoplastic 
activity, Ru(III) can also be employed in drug preparation. In fact Ru(III) can be 
activated through the so named “Activation by Reduction Mechanism”. This 
mechanism consists in the in vivo reduction of Ru(III) to Ru(II) with the aid of 
glutathione (GSH) or of other reducing proteins.
48  
 
  
Figure 1.7: Suggested mode of action of Ru-based anticancer agents. 
 
It is well-known that the growth of tumoral tissues needs a large quantity of oxygen 
for the formation of new blood-vessels (angiogenesis). However these vessels are not 
able to satisfy the continuous request of oxygen of the tumor cells. This gives rise to a 
mechanism of cellular hypoxia
49
 that has two important consequences. First, the 
tumor cells are compelled to migrate towards more oxygenated regions so starting 
the metastasis production. Second, the tumor cells dependent on glycolysis 
mechanism much more, in order to satisfy the request of energy and this has the 
secondary effect to produce an excess of lactic acid that lowers pH inside tumor 
cells.
50
 
Furthermore, there are evidences that hypoxia favors the binding of Ru-complexes to 
DNA,
51
 while it does not favor the binding of Pt-based drugs. The reason of this 
different mechanism probably stays in the octahedral geometry of Ru complexes in 
comparison with the planar geometry of Pt complexes.
52
  
The first Ruthenium based compound has been the so named NAMI, 
Na[transRuCl4(DMSO)(Na)], that showed encouraging antitumoral properties. This 
molecule has a pseudo-octahedral form with the four chlorines in equatorial position 
and the DMSO in axial. 
 
 
 
Figure 1.8: Chemical structures of NAMI (a) and NAMI-A (b). 
 
NAMI, then, was modified in NAMI-A, designed and synthesized by the research 
group of prof. Gianni Sava, university of  Trieste, substituting the counterion Na+ 
with the imidazole group. This substitution gave rise to a more stable complex, such 
that in 1999 the clinical trial of this compound started.
36
 It is supposed that NAMI-A 
is able to modify the gene expression of metastases cell, blocking the genes that 
sustain the malignant phenotype and activating, instead, the genes that regulate the 
normal growth and death of cells. 
Although a rather large number of studies on Ruthenium complexes have been 
published in the recent years,
53
 up to date in literature no examples of nanovectors 
carrying Ruhenium complexes are reported. 
 
 
2. The Systems Studied 
 
2.1 Peptides and Gd Complexes Containing Colloidal Assemblies as 
Tumor Specific Contrast Agents in MRI. 
 
The first system, that has been designed and characterized during this PhD thesis, 
has been a new amphiphilic supramolecular contrast agent able to give good and 
resolved images of human tissues and organs in Magnetic Resonance Imaging.  
The system should present two important aspects:  
1)   to display a very high relaxivity value 
2)   to be selective for cancer cells 
The two aims have been simultaneously achieved by working out mixed systems 
formed by two different amphiphilic unimers, one containing the chelating moiety 
DTPAGlu, capable of forming stable complexes with Gd3+ ions, and the other one the 
bioactive peptide CCK8.  
The first unimer had a double alkylic chain bound through a lysine residue to the 
DTPAGlu chelating agent (N,N-bis[2-[bis[2-(1,1-dimethylethoxy)-2-
oxoethyl]amino]ethyl]-L-glutamic acid). The second unimer contained the same 
lipophilic moiety bound through an oxyethylene glycol spacer to the C-terminal 
cholecystokinin octapeptide amide (CCK 26-33 or CCK8). CCK8 is the C-terminal 
sequence of the cholecystokinin hormone and provides the binding sequence for the 
cholecystokinin receptor subtypes A and B (CCKA-R and CCKB-R).
54
 Overexpression 
of both of these receptor subtypes has been demonstrated in certain human tumours: 
CCKA-R is overexpressed in pancreatic cancer, and CCKB-R is found in small cell 
lung cancer, colon and gastric cancers, medullary thyroid carcinomas, astrocitomas 
and stromal ovarian tumors.  
We have carried out several attempts to optimize the design of the CCK8 unimer, 
varying the length of the spacer situated between the double tail and the CCK8. In 
fact, the spacer should be long enough to assure an efficient exposure of the peptide 
on the external surface of the aggregate and at the same time short enough to favor 
the formation of vesicles.
55
 
The system so formulated, containing both unimers, has been investigated in 
different conditions of pH and ionic strength, due to the variety of environmental 
conditions the contrast agent may experience in the blood stream.  
 
 
 
 
 
 
 
 
 
 
 
2.2 Lipid Based Nanovectors Containing Ruthenium: A New Approach in 
Cancer Therapy 
 
Recently Ruthenium complexes have shown great potentialities in clinical use, but in 
spite of that in the open literature up to date no example of nanosystem carrying 
Ruthenium is reported. The use of nanovectors as carriers for Ruthenium complexes 
can improve the therapeutic efficacy of these complexes and reduce their systemic 
side-effects. 
The basic idea behind the project developed in this PhD thesis is the synthesis of a 
new amphiphilic molecule constituted by two oleoyl chains bound to an uridine 
residue containing a pyridinium ring able to coordinate a Ruthenium (III) complex.  
The molecules so designed can aggregate in nanovectors with different shape and 
size, such as spherical or rod-like micelles, vesicles/liposomes or other 
nanostructures.  
The amphiphilic unimer coordinating the Ruthenium, baptized DOPURu, has been 
lodged in lipid bilayer formed by DOPC (1,2-Dioleoyl-sn-Glycero-3-Phosphocholine) 
and DOPE (1,2-Dioleoyl-sn-Glycero-3-Phosphoethanolamine), to reduce the 
commercial cost of the final formulation. PC and PE polar heads are the most 
abundant in plasma membranes and are known to be compatible with cells. 
The system so formulated should guarantee an: 
1) Increased solubility of Ruthenium complexes in the bloodstream. 
2) Prolongation of the drug circulation time by protecting Ruthenium complexes 
from enzymatic and/or environmental degradation. 
3) Reduced Ruthenium complexes toxicity. 
These goals will be obtained because: 
1)  The lodgement of Ruthenium complexes in amphiphilic nanovectors consents 
to carry a higher amount of drug in the bloodstream compared to the case when it is 
administrated as free complex. 
2) The amphiphilic nanovectors are able to protect the Ruthenium complexes 
from enzymatic and/or environmental degradation that they could experience 
circulating in bloodstream.  
2) and 3) The presence of a poly(ethylene glycol)chain, PEG, in the backbone of our 
molecules, allows protecting Ruthenium complexes from enzymatic or environmental 
degradation, increasing so their circulation time in the bloodstream. A long time 
permanence of Ruthenium complexes in the bloodstream is advantageous from a 
therapeutic point of view, since the rapid uptake of colloidal drug carriers by RES 
(reticulo-endothelial system) would result in a fast reaching of the dose-limiting 
toxicity. 
3. Experimental Section 
 
3.1 Unimers Synthesis 
 
3.1.1 Synthesis of the Unimers Binding Gd and Peptides  
 
The unimers employed in the first project were synthesized by prof. Carlo Pedone’s 
research group (CIRPeB, Naples, Italy). 
The synthesis was carried out in solid phase (SPPS) by conjugation of DTPAGlu 
chelate or CCK8 peptide molecule (Figure 3.1) on a double hydrophobic tail of 18 
carbon atoms. 
We used two C18 chains to mimic the phospholipid bilayer of the cell membrane and 
to avoid so a possible cytholitic effect on the cells. 
DTPAGlu is the chelating agent used to coordinate Gd3+ ion. It’s a DTPA analog 
endowed of one carboxylic group more than DTPA molecule. This function permits to 
bind it on the double C18 chain and continue to preserve eight positions for the 
complexation of the paramagnetic ion.
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The CCK8 peptide monomer was synthesized binding the alkylic chains on the 
terminal amino group of CCK8 to assure that the peptide is still able to recognize 
selectively the cholocystokinin receptors (CCKA-R and CCKB-R), that are over-
expressed in tumoral processes. In fact, structural modifications on the N-terminal of 
the CCK8 should not affect receptor binding for both subtypes, because this part is 
distant from the receptor fragment and points towards the extra-cellular space. 
Some non-ionic ethoxylic spacers (AdOO) were placed between the peptide and the 
alkylic moiety in order to improve the hydrophilicity of the CCK8 peptide, and its 
exposition on the external aggregate surface. 
To improve the exposition of the peptide fragment, it was also synthesized another 
monomeric compound, where ethoxylic spacers were replaced by a poly(ethylene 
glycol) molecule. 
Notwithstanding the very promising properties of the already reported target-specific 
contrast agents, we thought that an increase of the efficacy in the development of 
selective contrast agents in MRI could be obtained by including, in the same 
molecule, all three fundamental tasks that are required: 1) a bioactive peptide, 2) a 
gadolinium complex, and 3) a hydrophobic moiety. We have, therefore, synthesized a 
new monomer with an “upsilon” shape (MonY; Figure 3.1), where a lysine residue is 
derivatized on its three reactive functions with: 1) the CCK8 peptide bound to the 
lysine carboxylic function and spaced by two oxyethylene linkers 2) the DTPAGlu 
chelating agent covalently bound to the side-chain ε-amino group and 3) a double 
C18 alkyl chain, where each chain was bound to the lysine α-amino group. 
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Figure 3.1: Schematic representation of the synthesized unimers. The amino acid sequence of CCK8 
peptide is reported  by using the one-letter amino acid code. 
 
3.1.2 Synthesis of the Unimer Binding Ru(III) 
 
The synthesis of the unimer binding Ru(III) has been carried out by Dr. Raffaella Del 
Litto and Prof. Francesco Ruffo.  
The new amphiphilic ligand, baptized DOPU, has been obtained from an uridine 
derivative by introduction of a pyridine function on the uracile base. The hydrophobe 
of the molecule is constituted by a double C18 alkyl chain attached to the C2 and C3 
of the sugar ring, whereas in position C5 an hydrophilic PEG-350 residue is present 
(see figure 3.2).  
 
 
Figure 3.2: Scheme of synthesis of DOPU unimer: I) nucleoside protection by dimethoxynitrile, II) 
alkyl chain introduction, III) nucleoside deprotection, IV) PEG350 residue introduction, V) pyridine 
function introduction. 
The ligand unimer DOPU has been coordinated to Ru(III) by displacing a DMSO 
molecule from the suitable precursor [(DMSO)2H][RuCl4(DMSO)2], as shown in 
figure 3.3. 
According to the stoichiometry of the reaction, the anionic molecule binding 
ruthenium [RuCl4(DMSO)(DOPU)]- is accompanied by the protonated unimer 
[(DOPU)H]+ as counterion. 
 
 
 
 
Figure 3.3: Scheme of the synthesis of DOPURu 
 
3.2 Sample Preparation 
 
The method of preparation of samples was evolved more times during the thesis, in 
order to find the right procedure to favor the formation of vesicles.  
The ordinary methods of sonication and extrusion were both used to give energy as 
much as possible to the system and to support so the formation of vesicles. 
All solutions were prepared by weighing; the solvent used was bi-distilled water or a 
buffer solution.  
Two different types of buffer solutions were used depending on the environmental 
conditions. For physiological condition, pH 7.4, a 0.10 M phosphate buffer solution 
was used, while for lower pH values a 0.10 M citric acid/phosphate buffer, that mixed 
at different ratios allowed moving from pH 7 to pH 3. pH measurements were made 
by using pH-meter MeterLab PHM 220. The pH-meter was calibrated with standards 
at pH 7, pH 10, and pH 3. 
The amphiphile unimers dissolved in the aqueous solvent were successively 
undergone to sonication for half a hour at 25°C in a bath-sonicator. Finally the 
resulting was extruded, pushing it 11 times through a polycarbonate membrane with 
100 nanometer pore size, to homogenize the size of vesicles. 
 
 
 
 
 
 
4. Results and Discussion 
 
4.1 Binary system: (C18)2DTPAGlu-water 
 
DLS measurements have shown that in (C18)2DTPAGlu solution, extruded at 
physiological pH, there is the contemporary presence of two different aggregates.  
Figure 4.1a shows the relaxation time distributions for 1 mM (C18)2DTPAGlu at 
different pH values. At pH 7.4 the distribution is clearly bimodal with well-separated 
modes, and in particular the fast mode has a higher amplitude than the slow mode. 
The relaxation rates ( 1τ −Γ = ) for the fast and the slow modes were measured at 
different q values. The linear relation of the relaxation rates confirms that both modes 
are due to translational diffusion processes, attributed to two different complexes, 
with apparent translational diffusion coefficients fastD  = (30.3 ± 0.4) × 10-12 m2s-1 and 
slowD  = (3.2 ± 0.5) × 10-12 m2s-1 respectively, see table 1. The Stokes-Einstein equation 
may be used to evaluate the hydrodynamic radius, RH  at infinite dilution: 
 
0 06
=
B
H
k TR
Dpiη
 (4.1) 
where 0D  is the translational diffusion coefficient at infinite dilution, Bk  is the 
Boltzmann constant, T  is the absolute temperature and 0η  is the solvent viscosity. 
Due to the high dilution (10-4 mol kg-1) and high ionic strength of the systems, we 
have approximately D≈ 0D  so eq. 1 can be reasonable used to estimate the 
hydrodynamic radius of the aggregates.  
The HR  values obtained for the slow and fast modes were (620±90) and (66±1) Å 
respectively, see table 1, and they are compatible with bilayer structures, such as 
vesicles, and micelles with an elongated shape.
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The relaxation time distribution of the (C18)2DTPAGlu solution at physiological pH 
collected in Figure 4.1a reveals the contemporary presence of micelles and bilayer 
structures or vesicles and that the dominant aggregates present in the system are 
micelles. The magnitude of the peak of this latter is sensibly higher than that 
corresponding to the vesicles. 
The intensity scattering profile collected by SANS confirmed these results, showing at 
intermediate q range (0.02 <q/Å-1< 0.06) a rising peak coming from the presence of 
micelles, whereas at low q values a q-2 decay typical of double layer scattering (see 
figure 4.2). Structural parameters of the aggregates have been obtained by fitting 
experimental data through an appropriate model (see appendix 2), and they are 
reported in table 2. Micelles have been modelled as rodlike micelles with a length of ~ 
200 Å and a radius of ~ 40 Å, while the bilayer thickness of vesicles was estimated to 
be around 70 Å.   
Variation of pH has a drastic effect on the size distribution of the aggregates. An 
overall view of the aggregation behavior may be obtained by plotting the intensity 
correlation functions or the relaxation time distributions obtained from RILT 
analysis of the former as a function of pH at a fixed scattering angle (θ = 90°) (Figure 
4.1 a-b). Figure 4.1 b shows that the time correlation function of scattered intensity 
g(2)(t)-1 translates to longer decay time as pH decreases, indicating a growth in the 
size of the aggregates. In particular in the pH range between 7.4 and 5.0 the 
relaxation time distributions (Figure 4.1 a) are substantially unvaried; the 
distributions are bimodal and the high amplitude peak at faster relaxation times 
corresponds to the diffusion of micelles.  
As pH decreases from 5.0 to 4.0, the picture changes: the distribution becomes 
almost monomodal and shifts toward slower relaxation times as expected for larger 
aggregates. Thus, subsequent acidification results in a further shift to slower times of 
the relaxation time. SANS measurements have highlighted that at pH 4.5 micelles 
increase their length from ~ 200 Å to ~ 700 Å. 
Further acidification at pH 3 favors the formation of vesicles, whose radius is 740 ± 
30 Å and thickness is 47 ± 5 Å.  
The results from the DLS and SANS measurements clearly show that the aggregation 
behavior is pH sensitive, this because of the presence of five carboxylic groups in the 
surfactant head-group. 
At physiological pH the tendency to form bilayer structures is sensible reduced, 
owing to the high negative actual charge of the surfactant head-group, which cause a 
strong head groups repulsion.  At lower pH (pH 5.0 – 4.0) the size distributions 
change as expected in light of the carboxylic acids pKa ~ 4.5.
58
 In fact around this pH 
the DTPA group should be partially uncharged, supporting the formation of large and 
low curvature aggregates, such as bilayer aggregates or vesicles. 
Thus for (C18)2DTPAGlu-water binary system, we have observed a micelle-to-vesicle 
transition, which confirms the three-stage Lichtenberg model.
16, 17
 
We have found the following sequence of aggregation states as the solution pH was 
decreased from pH 7.4 to 3.0 (see figure 4.3):  
                         rodlike micelles                 threadlike micelles                vesicles 
 
The cryo-TEM images collected in figure 4.3 give a clear indication of the structural 
evolution of the aggregates formed by (C18)2DTPAGlu as a function of the pH. The 
cryo-TEM results confirm a gradual transition upon decreasing pH from small rod-
like micelles (pH=7.4) to thread-like micelles (pH = 4.5), and finally to vesicles (pH = 
3.0). At physiological pH, micelles are visualized in the image as dark dots, because 
objects with a size of about 5-6 nanometers are in the limit of the resolution of 
electron microscopy technique used (see figure 4.3 a). At pH 4.5 micelles change their 
shape and appear in the vitrified sample as threads with slightly swollen end caps 
(figure 4.3 b).We note the aggregates seen in the image are characterized by a low 
contrast, which is typical of micelles. At pH 3 the images are dominated by the 
presence of vesicles, as foreseen from the DLS and SANS measurements. Most of the 
vesicles are unilamellar, see Figure 4.3 c, with a mean radius in the range of 
700÷1000 Å. This value is in agreement with the apparent hydrodynamic radius 
estimated by the DLS experiments. 
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Figure 4.1: (a) Relaxation time distributions at θ = 90° for 1mM (C18)2DTPAGlu aqueous solution as 
function of pH; (b) Intensity correlation functions at θ = 90° for 1mM (C18)2DTPAGlu aqueous 
solution as function of pH. 
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Figure 4.2: Scattering intensity profile for (C18)2DTPAGlu-D2O at pH 7.4 (), (C18)2DTPAGlu-D2O 
at pH 4.5 (), (C18)2DTPAGlu -D2O at pH 3 (), and (C18)2DTPAGlu-D2O at pH 7.4 not extruded 
( ).() Fitting curve to the experimental data through the model reported in the appendix. 
 
 
 
 
 
  
 
 
 
 
 
Figure 4.3: Cryo-TEM image for 1mM (C18)2DTPAGlu-water at different pH values: (a) at pH 7.4 
micelles appear as black dots which are difficult to distinguish from the background; (b) at pH 4.5 
thread-like micelles are observed (circular stains are artifacts); (c) at pH 3 vesicles appear unilamellar 
with a radius in the range of  700 ÷ 1000 Å. 
 
 
 
 
 
TABLES 
Table 1. Diffusion coefficients and hydrodynamic radii obtained from DLS 
measurements for the systems studied at different pH values. The terms fast and slow 
refer to micelles and bilayer structures respectively. 
 
 
Systems pH 
D fast×1011 
(m2s-1) 
R H 
(Å) 
D slow×1012  
(m2s-1) 
R H 
(Å) 
(C18)2DTPAGlu (0.0001 mol kg -1) – water 7.4 3.03±0.04 66±1 3.2±0.5 620±90 
(C18)2DTPAGlu (0.0001 mol kg -1) – water 6 3.01±0.01 66±1 2.81±0.11 710±40 
(C18)2DTPAGlu (0.0001 mol kg –1 ) – water 5 2.91±0.03 68±1 3.1±0.3 650±60 
(C18)2DTPAGlu (0.0001 mol kg -1) – water 4   5.0±1 400±80 
(C18)2DTPAGlu (0.0001 mol kg -1) – water 3   2.7±1 740±30 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Structural parameters of the aggregates at different pH values determined 
by Small-Angle Neutron Scattering (SANS). The terms Nagg, R and l refer to the 
aggregation number, the radius and the height of the micelles respectively, whereas d 
refers to the thickness of the bilayer structures. 
 
 
 
Systems 
 
pH 
 
Nagg 
R 
(Å) 
l 
(Å) 
d 
(Å) 
 
(C18)2DTPAGlu (0.00079 mol kg -1)-water 
 
7.4 
 
125±15 
 
39±3 
 
198±21 
 
72±9 
 
(C18)2DTPAGlu (0.00079 mol kg -1)-water  
(not extruded) 
  
7.4 
 
102±10 
 
38±4 
 
108±39 
 
 
(C18)2DTPAGlu (0.00063 mol kg -1)-water 
 
4.5 
 
771±80 
 
36±2 
 
710±60 
 
61±8 
 
(C18)2DTPAGlu (0.00063 mol kg -1)-water 
 
3 
    
47±5 
 
 
 
 
 
 
 
 
 
 
 
 
4.2 Binary system: (C18)2DTPAGlu(Gd)-water 
 
Systems where gadolinium ion was complexed by the chelating agent unimer 
exhibited quite similar relaxation time distributions and cross scattering profiles (see 
figures 4.4 and 4.5) to the systems in uncomplexed form when compared at the same 
condition of pH; although, as highlighted by SANS, double layer structures over the 
entire pH range were generally observed. In particular, DLS measurements have 
shown that below pH 6.0 the distribution becomes already monomodal. The relative 
amplitude for the slow mode increases on the expense of the fast mode yielding to a 
single peak positioned at a slower relaxation time at pH 4.0, see figure 4.4. 
The presence of Gd3+ ions produces a mild effect for the pH reduction, because it 
reduces the actual charge of the surfactant from -5 to -2. Thus, for these systems, 
formation of low and large curvature aggregates, such as open bilayers, is supported, 
and this tendency is further enhanced upon lowering the pH.  
At physiological pH, the cryo-TEM micrographs showed open bilayer structures and 
elongated and thick structures similar to fibers, corresponding to cylindrical micelles, 
see figure 4.6a. Upon decreasing pH, the images are dominated by the presence of 
bilayers structures as predicted by DLS and SANS results that are summarized in 
tables 3 and 4. The images collected for the system at pH 3.0 showed clearly the 
presence in solution of vesicles (figure 4.6 b) and open bilayers, similar to those 
visualized at pH 7.4. The radius of vesicles is ranged between 500 and 600 Å (table 
3). The latter structures, whereas, appear as hollow tubes having a thickness of 
around 60 Å with well marked edges. The edges appear quite dark probably because 
of the presence of the gadolinium, which is oriented toward the aqueous phase. These 
aggregates, as confirmed by DSC experiments, represent “gel phases” containing 
bilayers with crystallized hydrocarbon chains separated by liquid-like solvent whose 
gel to liquid-crystalline phase transition temperature 
mT  is around 70°C.
8
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Figure 4.4: Relaxation time distributions at θ = 90° for 1mM (C18)2DTPAGlu(Gd) aqueous solution 
as function of pH. 
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Figure 4.5: Scattering intensity profile for (C18)2DTPAGlu(Gd)-D2O at pH 7.4 (), 
(C18)2DTPAGlu(Gd)-D2O at pH 4.5 () and (C18)2DTPAGlu(Gd) -D2O ().() Fitting curve to the 
experimental data through the model reported in the appendix. 
 
 
 
 
 
 
  
 
   
 
 
 
Figure 4.6: Selected cryo-TEM images for 1mM (C18)2DTPAGlu(Gd)-water at different pH values: 
(a) at pH 7.4 open bilayers and cylindrical micelles similar to fibers appear (circular stains are 
artifacts); (b) at pH 3 vesicles with a radius in the range of  500 ÷ 600 Å. 
 
 
 
 
 
 
 
 
 
 
TABLES 
Table 3. Diffusion coefficients and hydrodynamic radii obtained from DLS 
measurements for the systems studied at different pH values. The terms fast and slow 
refer to micelles and bilayer structures respectively. 
 
 
Systems pH 
D fast×1011 
(m2s-1) 
R H 
(Å) 
D slow×1012  
(m2s-1) 
R H 
(Å) 
(C18)2DTPAGlu(Gd) (0.0001 mol kg-1) -water 7.4 2.64±0.05 76±1 4.1±0.3 490±50 
(C18)2DTPAGlu(Gd) (0.0001 mol kg 1) – water 6 2.64±0.03 76±1 3.2±0.4 620±80 
(C18)2DTPAGlu(Gd)(0.0001 mol kg -1) – water 5 2.50±0.05 80±2 4.3±0.2 460±20 
(C18)2DTPAGlu(Gd) (0.0001 mol kg 1) – water 4   5.6±0.3 360±20 
(C18)2DTPAGlu(Gd) (0.0001 mol kg 1) – water 3   6.3±0.2 320±20 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4. Structural parameters of the aggregates at different pH values determined 
by Small-Angle Neutron Scattering (SANS). The terms Nagg, R and l refer to the 
aggregation number, the radius and the height of the micelles respectively, whereas d 
refers to the thickness of the bilayer structures. 
 
 
 
Systems 
 
pH 
 
Nagg 
R 
(Å) 
l 
(Å) 
d 
(Å) 
 
(C18)2DTPAGlu(Gd) (0.00063 mol kg -1) -water 
 
7.4 
 
110±10 
 
35±3 
 
233±30 
 
52±5 
 
(C18)2DTPAGlu(Gd) (0.00063 mol kg -1) -water 
 
4.5 
 
723±65 
 
34±2 
 
741±82 
 
53±8 
 
(C18)2DTPAGlu(Gd) (0.00063 mol kg -1) -water 
 
3    
 
51±6 
 
 
 
 
 
 
 
 
 
 
 
 
4.3 Ternary systems: (C18)2DTPAGlu-(C18)2PEG2000CCK8-water and 
(C18)2DTPAGlu-(C18)2L5CCK8- water  
 
Once optimized the design of the chelating agent unimer; we then have carried out 
several attempts to optimize the design of the CCK8 unimer, varying the length of the 
spacer situated between the double tail and the CCK8. In fact, the spacer should be 
long enough to assure an efficient exposure of the peptide on the surface of the 
aggregates, as above mentioned, and in the meanwhile short enough to favor vesicles 
formation. Our study has been dealt with two unimers (see figure 3.1), one where the 
spacer consisted of 5 units of 8–amino-3,6-dioxaoctanoic acid ((C18)2L5CCK8), and 
the other one where the spacer was a poly(ethylene glycol) chain with an average 
molecular weight 2000 ((C18)2PEG2000CCK8).  
In figure 4.7 a we have reported the time correlation function of scattered intensity 
g(2)(t)-1 for both systems. The correlation function translates to longer decay time as 
the length of the spacer diminishes, indicating a growth in the size of the aggregates. 
In particular DLS measurements (figure 4.7 b) have shown for the (C18)2DTPAGlu-
(C18)2PEG2000CCK8 system a monomodal distribution corresponding to diffusion 
process of a complex with D= (1.7±0.1) × 10-12 m2s-1; whereas for the (C18)2DTPAGlu-
(C18)2L5CCK8 system the distribution was bimodal, indicating the presence of two 
aggregates with fastD = (30.9 ± 0.9) × 10-12 m2s-1 and slowD = (2.9 ± 0.2) × 10-12 m2s-1, 
respectively (see table 5). The dimension of the PEG coil is decisive in establishing the 
kind of aggregate, but also in assuring an efficient exposure of the peptide beyond the 
surface of the aggregate (see figure 4.9). Structural data obtained by SANS 
measurements are reported in table 6 and they have been used to estimate the 
percentage of covered surface by the PEG coil, that for (C18)2DTPAGlu-
(C18)2L5CCK8 is ~ 20%, while for (C18)2DTPAGlu-(C18)2PEG2000CCK8 is ~ 50%. A 
value of covered surface too high could reveal unfavorable for medical purposes, since 
it could prevent the contact between the peptide and the membrane receptors. Thus, 
our attention has been focused on (C18)2DTPAGlu-(C18)2L5CCK8 system. The 
relaxation time distribution for this system shows a similar profile to the 
corresponding binary system, but with respect to this latter in mixed aggregates the 
presence of the peptide unimer favors the formation of bilayer structures. As 
indicated by the magnitude of the relaxation time distribution, that in the same 
condition (total concentration, pH) appear sensibly larger than that found for the 
pure (C18)2DTPAGlu binary system. The presence of uncharghed peptide unimer that 
interposes between the charged headgroups of the chelating agent unimer decreasing 
the strong headgroup-headgroup electrostatic repulsions supports the formation of 
larger aggregates with a lower radius of curvature. SANS results have shown the 
extension of the 2q− increases as the amount of (C18)2L5CCK8 in the aggregates 
raises.  
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Figure 4.7: Intensity correlation functions at θ = 90º for 1mM (C18)2DTPAGlu-(C18)2PEG2000CCK8 
(solid line) and (C18)2DTPAGlu-(C18)2L5CCK8 (dashed line) aqueous solutions; (b) Relaxation time 
distribution θ = 90º obtained from regularized inverse Laplace transformation of the intensity 
correlation function for (C18)2DTPAGlu-(C18)2L5CCK8 and (C18)2DTPAGlu-(C18)2PEG2000CCK8 
aqueous solutions. 
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Figure 4.8: Scattering intensity profile for the following systems: (C18)2DTPAGlu-
(C18)2PEG2000CCK8-D2O (),(C18)2DTPAGlu-(C18)2L5CCK8-D2O (). (–) Fitting curve to the 
experimental data through the model reported in the appendix. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Figure 4.9: Schematic picture of the aggregates formed by our molecules according to SANS 
measurements. 
 
 
 
 
 
 
TABLES 
Table 5. Diffusion coefficients and hydrodynamic radii obtained from DLS 
measurements for the systems studied at different pH values. The terms fast and slow 
refer to micelles and bilayer structures respectively. 
 
 
Systems pH 
D fast×1012 
(m2s-1) 
R H 
(Å) 
D slow×1012  
(m2s-1) 
R H 
(Å) 
(C18)2DTPAGlu (0.00030 mol kg-1) - 
(C18)2L5CCK8 (0.00012 mol kg-1)-water 
7.4 30.9±0.9 64±2 2.9±0.2 690±40 
(C18)2DTPAGlu (0.00032 mol kg-1) - 
(C18)2PEG2000CCK8 (0.00015 mol kg-1)-
water 
7.4   1.7±0.1 125±25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6. Structural parameters of the aggregates at different pH values determined 
by Small-Angle Neutron Scattering (SANS). The terms Nagg, R and l refer to the 
aggregation number, the radius and the height of the micelles respectively, whereas d 
refers to the thickness of the bilayer structures. 
 
 
 
Systems 
 
pH 
 
Nagg 
R 
(Å) 
l 
(Å) 
d 
(Å) 
(C18)2DTPAGlu (0.00030 mol kg-1)–  
(C18)2L5CCK8 (0.00012 mol kg-1)-water 
 
7.4 
 
310±60 
 
36±7 
 
262±32 
 
68±9 
(C18)2DTPAGlu (0.00032 mol kg-1) - 
(C18)2PEG2000CCK8 (0.00015 mol kg-1)-water 
 
7.4 
 
120±10 
 
32±4 
 
200±20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.4 Ternary system: (C18)2DTPAGlu(Gd)-(C18)2L5CCK8- water 
 
The complexation of DTPAGlu with the paramagnetic Gd3+ ion decreases strongly the 
actual charge of the headgroup of the surfactant, and consequently also the high 
electrostatic repulsions between the different headgroups; favoring in turn the 
formation of vesicular aggregates. This is observed from the DLS results, where the 
relaxation time distribution was bimodal, as in the gadolinium free case, but was 
clearly dominated by the slow mode (see figure 4.10). The apparent translational 
diffusion coefficients obtained for the fast and slow modes were fastD = (33.2 ± 0.2) × 
10-12 m2s-1 and slowD  = (2.5 ± 0.3) × 10-12 m2s-1, with corresponding RH values of 61 ± 4 
and 810 ± 110 Å (see table 7). These results are in agreement with the SANS results, 
where a scattering profile with a power law of 2q− spans over a larger q  range, as 
shown in figure 4.11. The thickness of the lamellar aggregate containing gadolinium 
ion decreases from (68±9) to (53±8) Å, as shown in table 8. This suggests a better 
packing of the molecules in the double layer due the decrease of the electrostatic 
repulsions.  
The aggregation behavior for (C18)2DTPAGlu(Gd)-(C18)2L5CCK8 ternary system has 
also been studied as pH function, as shown in figures 4.9 and 4.10. The pH values 
selected for this study were pH 7.4, that corresponds to physiological pH condition; 
pH 4.5, because of the pKa of carboxylic acids; and finally pH 3, since extracellular 
fluid of tumor cells is acidic.  The decrease of pH leads to the formation of larger 
aggregates, such as the vesicular structures, that are further favored by the presence 
of the uncharged unimer (C18)2L5CCK8 (figure 4.10). In fact previous investigations 
have shown that in the absence of (C18)2L5CCK8, the (C18)2DTPAGlu system (as free 
base or as Gd3+ complex) at pH 4.5 forms either vesicles or micelles; in contrast when 
the (C18)2L5CCK8 is incorporated in the aggregates the micelles disappear in the 
system. 
Cryo-TEM images have shown at physiological pH the presence of elongated micelles, 
which appear as fibers, and planar symmetric bilayers. The latter appears as stiff 
tubular molecular arrangements long about 150 nanometers (figure 4.12 a). The 
images reveal that these bilayer structures tend to crowd all together forming a sort of 
texture having an asymmetric geometry. Upon lowering pH, as shown by scattering 
techniques, the tendency to form bilayer structures increases. At pH 3 the images 
were characterized by the presence of planar bilayers coexisting with vesicles with a 
diameter of around 120 nanometers (see figure 4.12 b). 
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Figure 4.10: Relaxation time distribution θ = 90º obtained from regularized inverse Laplace 
transformation of the intensity correlation function for (C18)2DTPAGlu(Gd)-(C18)2L5CCK8 as a 
function of pH. 
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Figure 4.11: Scattering intensity profile for the following systems: (C18)2DTPAGlu(Gd)-
(C18)2L5CCK8-D2O at pH=7.4 (),(C18)2DTPAGlu(Gd)-(C18)2L5CCK8-D2O at pH=4.5 (), 
(C18)2DTPAGlu(Gd)-(C18)2L5CCK8-D2O at pH=3 (). (–) Fitting curve to the experimental data 
through the model reported in the appendix. For a better comparison, cross sections have been 
multiplied for a scale factor. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.12: Selected cryo-TEM images for (C18)2DTPAGlu(Gd)-(C18)2L5CCK8 at different pH 
conditions: (a) pH 7.4, sandwiched bilayer structures; (b) pH 3, enlargement of the image of a vesicle. 
Scale bar = 50 nm. 
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TABLES 
Table 7. Diffusion coefficients and hydrodynamic radii obtained from DLS 
measurements for the systems studied at different pH values. The terms fast and slow 
refer to micelles and bilayer structures respectively. 
 
 
Systems pH 
D fast×1012 
(m2s-1) 
R H 
(Å) 
D slow×1012  
(m2s-1) 
R H 
(Å) 
(C18)2DTPAGlu(Gd) (0.00030 mol kg-1) - 
(C18)2L5CCK8 (0.00013 mol kg-1)-water 
7.4 33.2 ±0.2 61±4 2.5±0.3 810±110 
(C18)2DTPAGlu(Gd) (0.00032 mol kg-1) - 
(C18)2L5CCK8 (0.00015 mol kg-1)-water 
4.5   4.6±0.3 429±26 
(C18)2DTPAGlu(Gd) (0.00032 mol kg-1) - 
(C18)2L5CCK8 (0.00016 mol kg-1)-water 
3   2.9±0.2 669±40 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 8. Structural parameters of the aggregates at different pH values determined 
by Small-Angle Neutron Scattering (SANS). The terms Nagg, R and l refer to the 
aggregation number, the radius and the height of the micelles respectively, whereas d 
refers to the thickness of the bilayer structures. 
 
 
 
Systems 
 
pH 
 
Nagg 
R 
(Å) 
l 
(Å) 
d 
(Å) 
(C18)2DTPAGlu(Gd) (0.00030 mol kg-1) - 
(C18)2L5CCK8 (0.00013 mol kg-1)-water 
 
7.4 
 
270±40 
 
33±5 
 
269±42 
 
53±8 
(C18)2DTPAGlu(Gd) (0.00032 mol kg-1) - 
(C18)2L5CCK8 (0.00015 mol kg-1)-water 
 
4.5 
    
44±6 
(C18)2DTPAGlu(Gd) (0.00032 mol kg-1) - 
(C18)2L5CCK8 (0.00016 mol kg-1)-water 
 
3 
    
44±9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.5 Binary system: MONY-water and Ternary system: DOPC-MONY- 
water 
 
A further upgrade of the supramolecular system, studied up to now, is represented by 
the design and synthesis of a molecule containing contemporarily both active 
principles, and named as MonY. 
The relaxation time distribution for the binary system MonY–H2O (Figure 4.13), 
obtained by regularized inverse Laplace transformation (RILT) of the correlation 
function, was bimodal at all angles studied and consisted of a fast and a slow peak. 
Both peaks corresponded to the translational diffusion process of aggregates, because 
the relaxation rates had a linear dependence on the square of the magnitude of the 
scattering vectorq . Inspection of Table 9 shows that RH is (48±1) and (645±20) Å for 
the fast and slow peaks, respectively.  
Thus, the relaxation time distribution of the MonY–H2O system reveals the presence 
in solution of small micelles and larger aggregates, probably liposomal structures. 
The dominant aggregates in solution are micelles, even if the fast and slow peaks have 
a similar amplitude. In fact, we are considering an intensity-weighted distribution 
and not a number distribution. This leads to a dominance of the larger objects in the 
distribution, even if they are fewer in quantity.  
SANS measurements confirmed DLS results; in figure 4.14 the scattering cross 
sections d dΣ Ω obtained for the binary system MonY–D2O is represented. Inspection 
of the data reveals the presence of two different regions: a first region (q>0.01 Å-1) 
where the trend of a typical form factor of spherical or ellipsoidal micelles with weak 
or negligible interactions is present; and a second region (q< 0.01 Å-1) where an 
increasing of the magnitude of d dΣ Ω  holds. In this case, the data scale with a power 
law 2d d q−Σ Ω ∝ that can be ascribed to the scattering of the vesicular surfaces present 
in the system, induced by the extrusion process. Table 10 reports the parameters 
obtained from the fitting procedure. From the inspection of the table, it is possible to 
observe that MonY form oblate ellipsoidal aggregates composed by around 30 
unimers per aggregate, and where the ratio between the micellar axes is ~1.7. 
Structural data of vesicles have not been obtained in this case, since the number of 
data does not allow performing an accurate analysis. 
DLS and SANS measurements were also carried out on the mixed systems DOPC–
MonY–H2O, in order to determine the maximum MonY amount in the lipid bilayer 
such vesicular structures are not destabilized.  
Figure 4.13 displays the structural evolution of the aggregates obtained by assembling 
DOPC and MonY at different molar ratios. For a mixed sample containing 30% molar 
ratio of MonY, the distribution was bimodal and dominated by the slow peak; the fast 
peak (see arrow) had a very small amplitude. The relaxation rates (Γ=τ-1) for the fast 
and slow modes were measured at different q values. The linear relation of the 
relaxation rates confirms that both modes were due to translational diffusion 
processes, attributed to two different complexes with apparent translational diffusion 
coefficients fastD =(3.64±0.06)×10-11 m2s-1 and slowD =(2.9±0.1)×10-12 m2s-1, 
respectively (see Table 9). The corresponding hydrodynamic radii were (55±9) and 
(690±20) Å for the fast and slow modes, respectively. Scattering cross sections for 
this system confirmed DLS data. They showed a power-law 1d d q−Σ Ω ∝ , typical of 
rod–like structures, but for q< 0.009 Å-1 the scattering of vesicular bilayers was 
observed ( 2d d q−Σ Ω ∝ ), even if, like for the binary systems, number of data does not 
allow performing an accurate analysis. Concerning the analysis of rod-like micelles, 
the missing of the Guinier regime for such systems prevent to have an estimation of 
the length of these structures, but the 1q− regime is enough extended to have a 
reasonable value of the transversal radius r of rods. We have estimated that the 
radius value should be (35±1) Å (table 10). 
The increasing of the amount of DOPC in the mixed system results in a drastic change 
of the characteristics of scattering data. In fact, upon decreasing the MonY content 
(R= 80:20) the relaxation time distribution becomes monomodal, with a well-defined 
slow peak corresponding to liposomes (see figure 4.13). Concerning SANS data, the 
scattering cross sections for the systems, where the molar ratio was 80/20 or higher, 
scaled with a power law 2q− characteristic of scattering of planar sheets. DOPC 
molecules, as already known, form vesicular aggregates that retain their shape and 
characteristics until the MonY amount is smaller than 20% of the total concentration. 
In any case, a difference in absolute units of d dΣ Ω  occurs among the DOPC/D2O 
systems and the ternary samples where the power law 2d d q−Σ Ω ∝ holds. This leads 
us to conclude that vesicles should be mixed aggregates formed by DOPC and MonY. 
Cryo-TEM images confirmed scattering data. Figure 4.15 displays that the sample 
DOPC–MonY 80/20 was full of liposomes with a diameter ranging between 50 and 
150 nm. 
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Figure 4.13: Relaxation time distributions at θ=90º for DOPC–MonY–H2O ternary systems at 
different molar ratios (R=0, 70:30, 80:20, 90:10).  
 
 
 
 
 
 
 
 
  
 
0,01 0,1
1E-5
1E-4
1E-3
0,01
0,1
1
10
100
1000
10000
 
 
1cm
d d
−
Σ Ω
1Å
q
−
 
 
x 0.01
q–1
q–2
x 100
q–2
x 0.1
x 1
x 10
 
 
 
Figure 4.14: Scattering cross sections obtained at 25 ºC for the following systems: () 
MONY- D2O (c=2.1×10-3 mol kg-1), () DOPC–MonY–D2O (c=2.1×10-3 mol kg-1, R=70:30); () 
DOPC–MonY–D2O (c=1.9×10-3 mol kg-1, R=80:20); () DOPC–MonY–D2O (c=1.7×10-3 mol kg-1, 
R=90:10); () DOPC-D2O (c=2.5×10-3 mol kg-1). Curves fitted to the experimental data through an 
appropriate model are also reported. For a better comparison, cross sections have been multiplied for 
a scale factor. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 4.15: Selected cryo-TEM image for mixed system DOPC–MonY-water (R=80:20) 
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TABLES 
 
 
Table 9. Diffusion coefficients and hydrodynamic radii obtained from DLS 
measurements for the systems studied at different molar ratios phospholipid/unimer. 
The terms fast and slow refer to micelles and bilayer structures, respectively. 
 
 
Systems R 
D fast×1012 
(m2s-1) 
R H 
(Å) 
D slow×1012  
(m2s-1) 
R H 
(Å) 
MONY(0.00476mol kg-1) - water 0 41.4 ±0.1 48±1 3.1±01 645±20 
DOPC (0.00150 mol kg-1) –  
MONY(0.00064 mol kg-1)-water 
70/30 36.4±0.6 55±9 2.9±0.1 690±20 
DOPC(0.00154 mol kg-1) – 
MONY (0.00039 mol kg-1)-water 
80/20   2.8±0.1 700±20 
DOPC (0.00032 mol kg-1) –  
MONY(0.00024 mol kg-1)-water 
90/10   2.9±0.1 690±20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 10. Fitting parameters obtained from SANS data at 25°C for the systems 
MonY–D2O DOPC–MonY–D2O and DOPC- D2O through the equations reported in 
the text. The table displays the concentrations of the two solutes, the 
ratio DOPC
MONY
cR
c
= , the radius of cylinders r the three main semiaxis of the micellar 
hydrophobic core ( ,a b  and c ), the thickness of the micellar hydrophilic shellδ and 
the micellar aggregation number aggN . Finally, for the vesicular aggregates, the 
double layer thickness τ  is reported. 
 
 
DOPC
–1mmol kg
c
 
MonY
–1mmol kg
c
 R  Å
r
 Å
a
 Å Å
b c
=  Å
δ
 aggN  Å
gR
 
GUIN
Å
gR
 Å
τ
 
0 4.76 0  9 ± 1 27 ± 1 15 ± 1 32 ± 1 29 ± 2 28 ± 1 – 
0 1.20 0  10± 1 27 ± 1 16 ± 1 34 ± 1 30 ± 2 29 ± 2 – 
1.50 0.64 70/30 35 ± 1        
1.50 0.39 80/20  – – – – – – 38 ± 1 
1.54 0.24 90/10  – – – – – – 37 ± 2 
2.54 0 ∞   – – – – – – 36 ± 1 
 
 
 
 
 
 
 
4.6 Binary system: MONY(Gd)-water and Ternary system: DOPC-
MONY(Gd)- water 
 
MonY(Gd) containing systems were also studied. For the binary system MonY(Gd)–
H2O the relaxation time distribution was bimodal and dominated clearly by the large-
amplitude fast peak (see figure 4.16). Both peaks were found to have a linear 
dependence with respect to 2q . The diffusion coefficients were fastD =(4.15±0.03)×10-
11 and slowD =(3.4±0.3)× 10-12 m2s-1, and the hydrodynamic radii were (48±1) and 
(580±50) Å for the fast and the slow modes, respectively (Table 11). These values are 
similar to those corresponding to the Gd-free case; this indicates that the gadolinium 
complex does not modify significantly the kind and size of aggregates in solution. 
This observation is in agreement with SANS data, the structural data collected are 
similar to those of MONY-D2O binary system, as reported in table 12. The inspection 
of the scattering cross section reveals, also in this case, the presence of two different 
regions: one at high q values where a power law 1d d q−Σ Ω ∝  typical of rod like 
structures holds, and an other region at low qwhere the power law 2d d q−Σ Ω ∝ holds 
due to the presence of bilayer structures. 
Measurements were also carried out in mixed systems DOPC–MonY(Gd) to optimize 
the MonY(Gd) content in the lipid bilayer, and to find hence, as in the previous case, 
the right molar ratio between the two molecules where liposomes are the favored 
structures. At R=70:30 the relaxation time distribution was bimodal, as shown in 
figure 4.16. The diffusion coefficients obtained from the moments of the distribution 
were fastD =(2.90±0.09)×10-11 and slowD = (2.7±0.1)×10-12 m2s-1, and these values can 
be attributed to micellar and bilayer structures diffusing in solution. As for 
gadolinium uncomplexed systems, at R=80:20 the distribution appeared 
monomodal. This finding suggests that at this ratio the presence of MonY(Gd) did not 
destabilize the lipid bilayer, in fact when the ratio ( )DOPC MONY GdR c c=  is high enough 
(80:20) mixed vesicular structures formed by DOPC and MonY(Gd) molecules are 
present in solution. The values of the double-layer thicknessτ , extracted by SANS 
measurements and reported in table 12, showed values 35÷40 Å, that are comparable 
with those found for the ternary systems containing MonY in its uncomplexed form 
(≈ 37 Å). The radii of the vesicles measured by cryo-TEM (figure 4.18), analogously, 
ranged between 50-150 nm, as in the previous case. 
Indeed, liposome destabilization occurs when the volume fraction of MonY in the 
liposome bilayer reaches a value of ≈50%. This value has been calculated using the 
thickness of the bilayer, as obtained by SANS data, and the radius measured by cryo-
TEM.  
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Figure 4.16: Relaxation time distributions at θ=90º for DOPC–MonY(Gd)–H2O ternary systems at 
different molar ratios (R=0, 70:30, 80:20, 90:10). The arrow indicates the fast peak. 
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Figure 4.17: Scattering cross sections obtained at 25 ºC for the following systems: (	) MONY(Gd)-
D2O (c=3.0×10-3 mol kg-1), () DOPC–MonY(Gd)–D2O (c=1.8×10-3 mol kg-1, R=70:30); () DOPC–
MonY(Gd)–D2O (c=1.7 ×10-3 mol kg-1, R=80:20); () DOPC–MonY(Gd)–D2O (c=1.7×10-3 mol kg-1, 
R=90:10). Curves fitted to the experimental data through an appropriate model are also reported. For 
a better comparison, cross sections have been multiplied for a scale factor. 
 
 
 
 
  
 
 
 
 
 
 
Figure 4.18: Selected cryo-TEM image for mixed system DOPC–MonY(Gd)-water (R= 80:20) 
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Table 11. Diffusion coefficients and hydrodynamic radii obtained from DLS 
measurements for the systems studied at different molar ratios phospholipid/unimer. 
The terms fast and slow refer to micelles and bilayer structures, respectively. 
 
 
Systems R 
D fas×1012 
(m2s-1) 
R H 
(Å) 
D slow×1012  
(m2s-1) 
R H 
(Å) 
MONY(Gd)(0.0016 mol kg-1) - water 0 41.5 ±0.1 48±1 3.4±03 580±50 
DOPC (0.00137 mol kg-1) –  
MONY(Gd)(0.00048 mol kg-1)-water 
70/30 29.0±0.1 70±2 2.7±0.1 730±30 
DOPC(0.00139 mol kg-1) – 
MONY(Gd) (0.00027 mol kg-1)-water 
80/20   2.6±0.1 750±30 
DOPC (0.00134 mol kg-1) –  
MONY(Gd)(0.00014 mol kg-1)-water 
90/10   2.7±0.1 735±30 
 
 
 
 
 
 
 
Table 12. Fitting parameters obtained from SANS data at 25°C for the systems 
MonY(Gd)–D2O and DOPC–MonY(Gd)–D2O through the equations reported in the 
text. The table displays the concentrations of the two solutes, the 
ratio
( )
DOPC
MONY Gd
cR
c
= , the radius of cylinders r the three main semiaxis of the 
micellar hydrophobic core ( ,a b  and c ), the thickness of the micellar hydrophilic 
shellδ and the micellar aggregation number aggN . Finally, for the vesicular 
aggregates, the double layer thickness τ  is reported. 
 
 
 
 
DOPC
–1
mmol kg
c
 
 
( )MonY Gd
–1mmol kg
c
 
 
R  Å
r
 Å
a
 Å Å
b c
=  Å
δ
 aggN  Å
gR
 
GUIN
Å
gR
 Å
τ
 
0 
 
1.60 0  10 ± 1 27 ± 1 16 ± 1 36 ± 1 30 ± 2 29 ± 1 – 
0 
 
3.00 0  10 ± 1 27± 1 16 ± 1 35 ± 1 30 ± 2 29± 1 – 
1.37 
 
0.48 70/30 34 ± 1        
1.39 
 
0.27 80/20  – – – – – – 35± 1 
1.34 
 
0.14 90/10  – – – – – – 39 ± 2 
 
 
 
 
 
 
 
4.7 Pseudo-Binary system: DOPURu-water  
 
DOPURu vesicles were characterized by means of different techniques: dynamic light 
scattering (DLS), electron paramagnetic resonance (EPR), small-angle neutron 
scattering (SANS), and cryo-transmission electron microscopy (cryo-TEM). 
For DOPURu-water pseudo-binary system, the relaxation time distribution, obtained 
by regularized inverse Laplace transformation of the correlation function, was 
monomodal and consisted of a well-defined peak (see figure 4.19). The diffusion 
coefficientDwas estimated from the slope of the relaxation rate Γ , which is obtained 
from the first moment of the translational mode, as function of 2q . The value 
obtained was D= (3.1±0.2)×10-12 m2s-1, whereas the value of the apparent 
hydrodynamic radius, RH, evaluated using the Stokes-Einstein equation, was 
(700±50) Å (see table 13). This suggests that the molecule of new synthesis 
assemblies in aqueous solution forming aggregates larger than micelles, whose size is 
comparable to that of vesicles. 
EPR spectrum for DOPURu-water pseudo-binary system was indicative of the 
presence of bilayer structures (see Figure 4.20).  DOPURu-water dispersions were 
EPR silent, indicating the formation of aggregates in which the closeness between 
metal ions promotes strong spin exchange phenomena. In these conditions, the 
DOPURu structuring in the system can be investigated by using a proper spin-probe. 
EPR spectrum for phosphatidyl-choline spin-labeled on the 5-C atom of the sn-2 
chain (5-PCSL), inserted in DOPURu membranes (1:100 5-PCSL/DOPURu molar 
ratio), was indicative of the presence of bilayer s
splitting, 2Amax, measured as the difference between the low-field maximum and the 
high-field minimum (59.81±0.15) G was significantly higher than that observed for 
typical phospolipids (52.47±0.03) G, such as for DOPC (1,2-Dioleoyl-sn-Glycero-3-
Phosphocholine) and DOPE (1,2-Dioleoyl-sn-Glycero-3-Phosphoethanolamine). This 
suggests that the spin-labeled chains in DOPURu were lodged in a more rigid bilayer 
membrane with respect those lodged in DOPC and DOPE bilayer. 
SANS investigation confirmed the presence of vesicles in solution. The scattering 
cross section dΣ/dΩ showed, at low q range, a power law q α− ranging as 2<α<4 (see 
figure 4.21). This is typical of multilamellar vesicles, as also proved by cryo-TEM 
images, see figure 4.22, where unilamellar vesicles coexist with multilamellar ones.  
Thus, the SANS data were fitted through a model that accounted for the coexistence 
in the system of unilamellar and multilamellar vesicles. The structural parameters 
extracted from the SANS fitting procedure revealed that bilayer of the vesicles had a 
thickness,τ , of (35±3) Å. In particular the multilamellar ones showed an average 
number of lamellae, M, ≈ 3, while the average spacing, d, between the centers of two 
lamellae was about (50±1) Å.  
Cryo-TEM micrographs, shown in figure 4.22, were in agreement with EPR and 
scattering techniques results. The images showed the presence of vesicles of various 
types, unilamellar and multilamellar, with a radius of about 600-700 Å.  
Figure 4.23 represents a cartoon of how the system formulated should work. 
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Figure 4.19: Relaxation time distributions at θ=90º for DOPURu-water pseudo-binary system. 
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Figure 4.20: EPR spectra obtained at 25ºC for 5-PCSL inserted in DOPURu and DOPC-DOPE 
membranes, respectively. 
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Figure 4.21: Scattering cross sections obtained at 25 ºC for DOPURu-water pseudo-binary system 
together with the curve obtained from the fitting model. 
 
 
 
 
 
 
 
  
 
Figure 4.22: Cryo-TEM images showing (A) oligolamellar and (B) unilamellar vesicles. (Globular 
stains in figure 4A are artifacts). 
 
 
 
  
 
 
 
 
 
 
Figure 4.23: Schematic representation of the system should work. 
 
 
 
 
 
 
 
 
 
 
 
 
4.8 Pseudo-Quaternary system: (DOPC-DOPE)-DOPURu-water  
 
The amphiphilic molecule coordinating the Ruthenium, DOPURu, has been lodged in 
mixed liposomes of DOPC (1,2-Dioleoyl-sn-Glycero-3-Phosphocholine) and DOPE 
(1,2-Dioleoyl-sn-Glycero-3-Phosphoethanolamine), to reduce the commercial cost of 
the final formulation. PC and PE polar heads are the most abundant in plasma 
membranes and are known to be compatible with cells. 
The aggregation behavior of the (DOPC-DOPE)-DOPURu-water quaternary system 
has been studied as a function of DOPURu amount by means of different techniques. 
Figure 4.24 shows the relaxation time distributions collected by DLS. All the analyzed 
systems were characterized by the presence of one single broaden peak. The RH of the 
aggregates ranged from (880±70) to (750±80) Å, and was consistent with the 
presence of bilayer aggregates, such as vesicles. 
SANS measurements confirmed the presence in solution of bilayer aggregates for the 
quaternary systems at all molar ratios studied (70:30, 60:40 and 50:50). The 
scattering cross sections dΣ/dΩ showed, at low q range, a power law q α− ranging as 
2<α<4 (see Figure 4.25). In particular, at lower surfactant/phospholipid ratios 
(60:40 and 50:50) the scattering cross sections appeared different compared to that 
of DOPC-DOPE pure system. A diffraction peak was visible at intermediate q range, 
rising probably from intra-lamellar interference, whereas at low q range the slope was 
ranging between q-3 and q-4. 
EPR study for the pseudo-quaternary systems, analogously to the binary system, was 
performed introducing in the bilayer membrane an opportune probe: 5-PCSL. EPR 
spectra (see figure 4.26) evidenced that for the quaternary system 70:30 
phospholipid/surfactant molar ratio the 2Amax assumes a value (52.40±0.10) G, and 
is similar to that registered for the DOPC-DOPE pure system. This suggests that in 
correspondence of this molar ratio, the DOPC-DOPE bilayer is not significantly 
perturbed by the presence of DOPURu. 
On these bases, cryo-TEM investigation was carried out on the aqueous system 
(DOPC-DOPE)-DOPURu 70:30. In figure 4.27 are reported selected cryo-TEM 
images. The images show a rich variety of aggregates: unilamellar vesicles, 
cubosomes and vesicles with a highly ordered cubic inner structure. 
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Figure 4.24: Relaxation time distributions for the (DOPC-DOPE)/DOPURu-water quaternary 
systems at different phospholipid/surfactant molar ratios: 70:30, 60:40, 50:50. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.25: Scattering cross sections obtained at 25 ºC for the following systems: () DOPC–
DOPE–D2O, () (DOPC–DOPE)–DOPURu–D2O (R=70:30), () (DOPC–DOPE)–DOPURu–D2O 
(R=60:40), (	) (DOPC–DOPE)–DOPURu–D2O (R=50:50). For a better comparison, cross sections 
have been multiplied for a scale factor. Lines are a guide for the eye.  
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Figure 4.26: EPR spectra obtained at 25ºC for 5-PCSL inserted in (DOPC-DOPE)-DOPURu, 
DOPURu and DOPC-DOPE membranes, respectively. 
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Figure 4.27: Cryo-TEM images for (DOPC-DOPE)-DOPURu 70:30 system. The images show the 
coexistence of unilamellar vesicles with cubosomes. 
 
TABLE 
 
 
Table 13. Diffusion coefficients and hydrodynamic radii obtained from DLS 
measurements for the systems studied at different molar ratios phospholipid/unimer. 
The terms fast and slow refer to micelles and bilayer structures, respectively. 
 
 
Systems R 
D×1012 
(m2s-1) 
R H 
(Å) 
DOPC–DOPE–water ∞  3.2±0.3 650±60 
(DOPC–DOPE) –DOPURu–water 70/30 2.5±0.2 880±70 
(DOPC–DOPE) –DOPURu–water 60/40 2.6±0.3 850±100 
(DOPC–DOPE) –DOPURu–water 50/50 2.9±0.3 750±80 
DOPURu–water 0 3.1±0.2 700±50 
 
 
 
 
 
5. Conclusions 
 
The present PhD thesis work has dealt with the development and the upgrade of 
innovative amphiphilic supramolecular systems to be used in cancer diagnosis and 
therapy.  
Two are the main systems that have been formulated during these 3 years of PhD: 
one based on Gadolinium complexes to be employed as contrast agent in Magnetic 
Resonace Imaging, and the other one consisting in a nano-vector able to deliver Ru 
(III), the most promising metal for cancer therapy.  
The most remarkable aspect of these systems is their bio-selective behavior toward 
the ill tissues. Two different strategies have been followed to achieve this goal: the 
first system was able to carry a high amount of Gd (III) ions towards tumor cells by 
means of the presence of a peptide, CCK8, on the external surface of the aggregates; 
the second system, whereas, was able to deliver cytotoxic Ru (II) by a mechanism of 
activation in situ; thanks to the internal reductive environment typical of cancer cells 
Ru (III) reduces to Ru (II).  
The physico-chemical characterization of the systems, here presented, has 
significantly supported the understanding with regard to their aggregation behavior 
and structural properties. In particular, it has been shown that structural properties 
can be modified and tuned according to the exigencies for a future clinical use of the 
systems.  
Collection of structural data allowed, for instance, determining the critical molar ratio 
DOPC-MONY or (DOPC-DOPE)/DOPURu where bilayer aggregates are stable. 
Bilayer aggregates, such as vesicles or cubosomes, are characterized by sluggish 
monomer exchange processes. This feature makes this kind of aggregates less 
dangerous for cellular membranes compared to micelles, and therefore their use is 
more favored.  
An other important example is the determination of the right length of the spacer in 
the peptide unimer (C18)2LxCCK8, such that the bio-active sequence of CCK8 was 
well-exposed and well-separated on the external surface of the aggregates, and able, 
thus, to interact with its target membrane receptors.  
Particular emphasis has been provided to the study of the aggregation behavior as pH 
function. Recent studies have revealed, in fact, that the extracellular fluid of tumor 
cells has a pH lower than that of healthy tissues, so that there has been an increasing 
demand in current clinic for pH-responsive systems. 
Gadolinium containing systems demonstrated particularly suitable as pH-sensitive 
aggregates, this because of the high actual charge of the head group of the chelating 
agent unimer (C18)2DTPAGlu.  
Upon decreasing the pH value in solution, a micelle-to-vesicle transition in three 
stages has been observed:  
 
                  rodlike micelles                 threadlike micelles                vesicles 
 
as result of the screening of the intra-aggregate electrostatic repulsions among the 
different head-groups. This property of the system can be applied to realize pH-
responsive MRI contrast agents able to supply the in vivo pH mapping of tissues in 
tumor diagnosis. 
The findings presented in this study opens up novel and interesting opportunities to 
investigate surfactant aggregation properties, that may be exploited in several 
applications, such as in drug and gene delivery or in medical diagnostic. 
The active principles used can be easily substituted from new ones, in order to make 
more appealing the formulated systems from an applicative point of view. At this aim, 
we are considering different bio-active molecules, such as the hyaluronic acid (HA) 
for its applications in lung cancer therapy and the octreotide, a peptide analogous of 
the somatostatine, for breast cancer. In the first case, we are carrying out in 
laboratory experiments, in order to bind covalently fragments of HA on the external 
surface of DOPE liposomes by means of the formation directly in the bulk of a 
peptide bond between the ethanolamine of DOPE and the carboxylic groups of HA. In 
the second case, a molecule with similar characteristics to (C18)2L5CCK8 has been 
synthesized (see figure 6.1). 
 
 
 
Figure 5.1: Schematic representation of the unimer (C18)2L5Octreotide. 
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6. DOES THE SYSTEM WORK? 
 
The applicative properties of the Gadolinium containing systems have been studied in 
specialized centers in Italy. 
The two main aspects have been investigated:  
1) relaxivity evaluation by water proton relaxation measurements (NMRD);  
2) selectivity assay for cancer cells by test in vivo on mice. 
 
6.1 Water proton relaxation measurements 
 
Water proton relaxation measurements were carried out by prof. Silvio Aime’s group 
(Departement of Chemistry IFM, University of Turin). 
The complexation of DTPAGlu chelating agent with gadolinium ions has been carried 
out on micellar solution.  
Upon addition of increasing amounts of a concentrated GdCl3 solution to the 
(C18)2DTPAGlu water solution, the chelating ligand DTPAGlu became progressively 
saturated. The Gd3+ titration was followed by measuring 1H-relaxation rates. 
The proton relaxivity value measured, at 20 MHz and 298 K, for binary system 
(C18)2DTPAGlu(Gd)-D2O was 17.5±1.7 mM-1s-1. This value is markedly larger than 
that measured for the simple complex DTPAGlu(Gd), 6.2±06 mM-1s-1. The slow 
rotation of the (C18)2DTPAGlu(Gd) micelle decreases the longitudinal relaxation time 
of the water protons bound to the Gd3+ and produces a substantial raise of the 
relaxivity. 
Relaxivity measurements on (C18)2DTPAGlu(Gd)-(C18)2L5CCK8-D2O and 
(C18)2DTPAGlu(Gd)-(C18)2PEG2000CCK8-D2O ternary systems were performed 
using mixed micelles prepared with (C18)2DTPAGlu(Gd). The measured relaxivity 
values for these species were 16.3±1.6 mM-1 s-1 and 13.4±1.3 mM-1 s-1 respectively at 
20 MHz and 298 K (Figure 6.1).   
Finally, for MONY(Gd)-D2O and DOPC-MONY(Gd)-D2O systems the values obtained 
were 15.0± 1.5 mM-1 s-1 and 12.7±1.3 mM-1 s-1, respectively. 
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Figure 6.1: Nuclear Magnetic Resonance Dispersion profiles of (C18)2DTPAGlu(Gd)-(C18)2L5CCK8-
D2O (○) , (C18)2DTPAGlu(Gd)-D2O (●) solutions at pH 7.4 and 25°C, normalised to 1 mM 
concentration of Gd3+ ion. 
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Figure 6.2: Nuclear Magnetic Resonance Dispersion profiles of MONY(Gd) (), DOPC-MONY(Gd)-
D2O () solutions at pH 7.4 and 25°C, normalised to 1 mM concentration of Gd3+ ion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 TABLE 
 
 
Table 6.1: Relaxivity values measured at 20 MHz and 298 K. 
  
 
Systems r1p(mM-1s-1) 
DTPAGlu(Gd) – D2O 6.2±0.6 
(C18)2DTPAGlu(Gd) – D2O 17.5±1.7 
(C18)DTPAGlu(Gd) – (C18)2L5CCK8 – D2O  16.3±1.6 
(C18)2DTPAGlu(Gd) – (C18)2PEG2000CCK8– D2O 13.4±1.3 
MONY(Gd) – D2O 15.0±1.5 
DOPC-MONY(Gd) –  D2O 12.7±1.3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.2: In Vivo Evaluation of the system 
 
In vivo evaluation of the mixed aggregates was performed to verify the bio-specificity 
of the supramolecular aggregates formulated in this thesis.  
The experiments consisted in nuclear medicine tests, that were carried out by dr. 
Luigi Aloj at the Italian National Institute for Tumours, G. Pascale, Naples, Italy.  
The experiments were realized on mice, where two different type of tumours were 
allowed to grow for two weeks. One tumour was selective for the CCK8 peptide, and it 
was placed in the left thigh of the mice, while the other one not showing affinity for 
CCK8, it was used as control tumour and was placed in the right thigh. 
The aggregates injected in the mice were mixed aggregates, containing the peptide 
monomer, (C18)2PEG2000CCK8, and the chelating agent monomer binding In3+, 
(C18)2DTPAGlu(In). (C18)2DTPAGlu(In)-(C18)2Peg2000CCK8 aggregates were 
prepared by dissolving monomers at a 5 to 1 ratio (chelator containing vs peptide 
containing) with final concentration in the 10-2 M range. Trace amounts of 111InCitrate 
were added and the suspension was allowed incubating at room temperature for 30 
min. Proof of aggregate formation and labelling with 111In was obtained by gel 
filtration chromatography in comparison to In-Citrate which was run as control. 
The aggregates prepared as described above were injected into nude mice bearing 
subcutaneous xenografts in opposite thighs (receptor positive in left thigh, receptor 
negative in right thigh). One hundred µL of 111In labelled aggregate suspension was 
injected in the tail vein of the animals. After 16 h the animals were killed, imaged with 
a medium energy collimator equipped clinical gamma camera, and subsequently 
dissected to evaluate organ distribution of radioactivity. 
 
 
 
   
 
 
 
 
 
 
 
 
Figure 6.2: γ-camera image obtained at16 hours the injection after injection of the aggregates. 
 
The figure 6.2 shows a gamma camera image. The receptor overexpressing tumour 
compatible for CCK8 peptide clearly shows higher uptake compared to the control 
tumour. Radioactivity levels were elevated in blood and in all high blood pool organs 
(liver, spleen). There appeared to be no overall loss of radioactivity from the animals 
over the 16 h observation period, indicating the aggregates were extremely stable. The 
receptor expressing tumours were the highest concentrating tissue after liver and 
spleen. On average CCKBR overexpressing xenografts contained 6.9 + 1.7 % of 
injected dose per gram (%ID/g) against 5.1 + 1.1 %ID/g for control tumours (mean + 
SD). 
This confirmed that the aggregates were able to recognize selectively the 
cholocystokinin receptors (CCKA-R and CCKB-R) over-expressed in the left thigh 
 
 
 
tumour. But, it is noteworthy that a great amount of radioactivity was accumulated in 
correspondence of the liver and the spleen (the yellow spot in the middle of the 
mouse body), indicating a problem of expulsion from the body of the aggregates by 
urinary vie. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 2 
 
7.1: Dynamic Light Scattering (DLS) 
 
The dynamic light scattering (DLS) is a technique widely used to study the dynamical 
properties of colloidal dispersions.  
In a DLS experiment the fluctuations of the scattered light intensity are measured as 
a function of time at a constant scattering angle. These intensity fluctuations occur 
because the particles in solution are in constant motion, the Brownian motion. The 
analysis of the intensity fluctuations allows the determination of the distribution of 
diffusion coefficients of the particles, which are converted then into a size distribution 
using established theories.
59,60
 In DLS the temporal variation of the intensity is 
measured and is represented usually through the so-called intensity autocorrelation 
function. Since, in general, it is not convenient to deal with a large intensity values as 
function of time, one reduces the intensity fluctuations to the autocorrelation 
function (2) ( )G t .  The intensity correlation function measures the correlation between 
the intensity value ( )I t at a generic time ( )t and the intensity value ( )dI t t+ being dt the 
time delay. 
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where ( ,0)I q and ( , )I q t are the intensities of the scattered light at delay 
time 0t = and t t= , respectively. 
Its normalized value, (2) ( )g t , is defined by : 
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where (2) (0)G is the time-averaged value of the square intensity, i.e. 〈I(t)2〉. 
The models used in the fitting procedures are expressed with respect to the 
normalized time correlation function of the electric field, (1) ( )g t , because the time 
correlation function of scattered light is not simply related to the motion of the 
molecules. 
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The two normalized time correlation functions are related by Siegert’s relationship:
61
 
 
 
2)1()2( )(1)( tgtg β=−  (7.4) 
 
where β( 1≤ ) is the coherence factor, which accounts for deviation from ideal 
correlation and depends on the experimental geometry. 
For a monodisperse system, (1) ( )g t will decay as a single exponential function with a 
characteristic relaxation time τ : 
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 ( )τttg −= exp)()1(  (7.5) 
 
whereas for a polydisperse system (1) ( )g t will be multiexponential and may be 
expressed as a Laplace transformation of a distribution of relaxation times, (A )τ :                                           
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where 1τ −= Γ and Γ is the relaxation or frequency rate.  
The relaxation time distribution ( )Aτ τ  is obtained by regularized inverse Laplace 
transformation (RILT) of the measured intensity correlation function using 
calculation algorithms. In the analyses in this work, algorithms of two commercial 
programs have been used: REPES,
63,64
 incorporated in the GENDIST analysis 
package,
64,65
 and RILT incorporated ALV-5000/E software. 
The relaxation rate Γ  is obtained from the first moment of the relaxation time 
distribution, and from its value is possible to estimate the apparent translational 
diffusion coefficientD , through this relation: 
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 (7.7) 
 
where q is the absolute value of the scattering vector (q = 4 pi n0 sin (θ/2) / λ, where n0 
is the refractive index of the solvent, in this work is water, λ is the incident 
wavelength and θ is the scattering angle). 
D  is, thus, obtained from the slope of Γ  as a function of 2q , where Γ  is measured at 
different scattering angles. 
The diffusion coefficient D  obtained in a DLS experiment is believed to be the 
mutual diffusion coefficient. The Brownian motion generates concentration 
fluctuations that in turn produce a chemical potential gradient and the associated 
flow is proportional to this gradient through a coefficient called the mutual diffusion 
coefficient, which can be described by Fick’s second law:
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where pi  is the osmotic pressure of the dispersion and c  is the concentration of the 
solute. 
In particular for infinite dilute dispersions:  
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D reduces to the self-diffusion coefficient 0D and we obtain the Stokes-Einstein 
equation: 
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7.2 Small angle neutron scattering (SANS) 
 
SANS is a small angle scattering technique that exploits the wave-particle duality of 
the neutron and its unique nuclear properties to provide information about the size 
(length scale varies from 1 to 1000 nm) and shape of molecules and their assemblies. 
In SANS, the scattering vectorq is used to describe the relationship between the 
incident and the scatter wavevectors. Its module, q , is the independent variable in a 
SANS experiment and has magnitude ( )2 sin 2q pi θ λ= and dimensions of (length)-1. 
By combining qwith the Bragg law of diffraction, one obtains the simple and useful 
relationship: 2d q
pi
= , from which the molecular-level length scale ( d ) at any 
accessibleq can be obtained. The dependent variable in a SANS experiment is the 
differential scattering cross-section, (dΣ/dΩ), improperly also called intensity of 
scattering ( )I q . Scattering cross section d dΣ Ω contains information on interactions, 
size and shapes of aggregates present in the system, and can be expressed for a 
collection of monodisperse bodies as 
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 ( ) ( ) ( )
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d dq n P q S q
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σΣ  
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 (7.11) 
where pn represents the number density of the scattering object present in the system, 
( )P q and ( )S q are respectively the form and the structure factor of the scattering 
particles, whereas ( )inchd dΣ Ω takes into account for the incoherent contribution to the 
cross section measured, mainly due to the presence of hydrogenated molecules. The 
form factor contains information on the shape of the scattering objects, whereas the 
structure factor accounts for inter-particle correlations and is normally important for 
concentrated or charged systems. Provided that solutions are quite dilutes (c<10-3 
mol kg-1) the structure function ( )S q can be approximated to the unity, and the 
scattering cross section is reduced to 
 ( ) ( )
inch
p
d dq n P q
d d
σΣ  
= +  Ω Ω 
 (7.12) 
Microstructural parameters of the aggregates have been obtained by applying the 
appropriate model to the experimental SANS data. Experimental data have shown in 
the analyzed systems the existence of cylindrical micelles and/or the presence of 
vesicular aggregates. 
Scattering from cylindrical structures is characterized by a region where the 
1
~d d q−Σ Ω power law dependence holds. The single particle form factor for such 
micelles can be written as 
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 (7.13) 
where l  is the length of the cylinders, R the radius of the base, whereas 1j is the first 
order Bessel function and 0cρ ρ− the scattering length density difference between the 
cylinders and the solvent. 
Vesicular aggregates cannot be observed in their completeness since the Guinier 
region of such objects falls almost completely in the USANS domain. As consequence 
the SANS region is characterized by a power law 2~d d q−Σ Ω due to the scattering of 
vesicular double layer. Indeed theq range spanned by the SANS measurements is 
such to allow regarding the vesicles as randomly oriented planar sheets for which the 
form factor can be expressed by 
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where d  is the plane thickness, and S is the plain surface per unit volume. 
Scattering from solutions containing cylindrical structures has been analyzed by 
using eqs 7.12 and 7.13, whereas in the systems containing vesicles aggregates, eqs 
7.12 and 7.14 have been used. Systems containing both the objects have been treated 
assuming each kind of aggregate scattered independently from the other and 
expressing the cross section as the sum of the form factors weighted for two scale 
factors (Kcyl, Ksheets) the relative number density of the objects 
 ( ) ( ) ( )
inch
p cyl cyl sheets sheets
d dq n K P q K P q
d d
σΣ  
= + +  Ω Ω 
 (7.15) 
and treating the scale factors as adjustable parameters.  
 
 
 
 
 
 
7.3 Cryo-Transmission electron microscopy (Cryo-TEM) 
 
Structures formed by amphiphilic molecules can be visualized by several microscopy 
techniques, but the more promising is the transmission electron microscopy, which 
was originally developed by Knoll and Ruska in Germany in the 1930’s.  
In a transmission electron microscope, a beam of electrons is sent trough a thin 
sample. An electron source situated at the top of the instrument emits electrons, 
which are accelerated by a high voltage. The wavelength of the electrons is dependent 
on the accelerating voltage of the microscope. The electron source, the so-called 
filament, usually consists of a LaB6 cathode. The electron beam is focused onto the 
specimen by condenser lenses. The objective lens, situated below and around the 
specimen, forms the image and controls the contrast. Finally a set of projector lenses 
enlarges the image and projects it onto fluorescent screen. The image can also be 
transferred to a photographic film or an electron sensitive camera. To perform TEM 
experiments is necessary to respect some requests: the samples must be thin enough 
(< 0.25 µm) to permit electrons to pass through them, moreover, to prevent image 
blurring, all motion on the supramolecular scale must be arrested. To achieve these 
conditions, different ways of preparation of TEM sample have been developed, one of 
them is the so called Cryogenic TEM, which is based on the rapid freezing of sample. 
In fact, with the term cryo-TEM, we mean transmission electron microscopy of thin 
vitrified aqueous films, kept at liquid nitrogen temperature,
70,71
 in order to reduce the 
vapour pressure and to stop all the supramolecular motions. 
 Figure 7.1: Picture of the cryo-electron microscope used, a Philips CM120 BioTWIN operating at 120 
kV. 
 
This technique has during the last 10 years contributed significantly to the 
understanding of the numerous, and often complex, structures formed by 
amphiphilic molecules in dilute aqueous solutions.
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In the cryo-TEM method the solution is applied to a microscopy grid in such a way 
that a very thin aqueous film is formed, which then is plunged into a cooling medium, 
such as ethane just above its freezing point, where the film rapidly vitrifies, without 
crystallisation. The grid with the vitrified film is then transferred to the microscope, 
and examined at liquid nitrogen temperature in transmission mode. The structures, 
which in this way are captured in the vitrified film, are so quickly vitrified that 
normally no important reorganisation takes place. 
The fact that the film is thin in the middle and thicker at the edges can introduce a 
size separation, small objects will tend to be accumulated in the middle of the film 
and larger objects at the edges. 
A limiting factor is represented by the contrast, it derives from the difference in 
electron density between the atoms of the amphiphile and the surrounding water, 
and it is necessary to underfocus the image to improve the contrast.  
Other limiting factors are due to the dimensions of the aggregates: the smallest size 
that can be resolved is about 4-5 nm, so micelles are seen only as dots, the upper size, 
instead, is about 500 nm.   
The technique is generally perfect to visualize structures as those presented in this 
thesis, formed by bilayers as vesicles or cubosomes. Vesicles of various kinds and in 
different stages (open bilayers, fusion phenomena, etc.)  of transformation can be 
investigated, it is possible see the rounded shape and the inner aqueous 
compartment, so it can for example distinguish between a multilamellar and a 
unilamellar vesicle, and estimate also the radius of the aggregates. 
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